The Federal Trade Commission published a second interim staff report this week on the prescription drug middleman industry, which ...
The pressure against pharmacy benefit managers (PBMs ... Express Scripts and Optum Rx) on specialty generic drugs, highlighting substantial price markups by PBMs on medications for cancer ...
Pharmacy benefit managers CVS Caremark, OptumRx and Express Scripts inflated costs for specialty generic drugs to treat diseases such as cancer and HIV to the tune of $7.3 billion over six years ...
industry dominance and marking up the prices of specialty drugs. The report specifically looked at the business practices of the Caremark Rx, Express Scripts and OptumRx, which are in turn owned ...
FTC: ‘Big 3’ Pharmacy Benefit Managers Engaged in Price Gouging, PBMs, UnitedHealth OptumRx, CVS Caremark Rx, Express Scripts ...
CVS Caremark, Express Scripts and OptumRx dramatically ... The FTC’s findings—which analyzed 51 specialty generic drugs from 2017 to 2022—showed these pharmacy benefit managers’ (PBMs ...
Drug distributor Cardinal Health on Thursday raised its fiscal 2025 adjusted profit forecast as strong demand for costly specialty medicines and branded drugs drove sales at its pharmaceuticals unit.
Dealbreaker on MSN14d
Pharmacy Benefit Managers Not Thrilled With FTC Report Finding Pharmacy Benefit Managers Raise Drug PricesThe pressure against pharmacy benefit managers (PBMs) continues to build. On Tuesday, the Federal Trade Commission released ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback